IDSA: Three-Dose Hepatitis B Vaccine Highly Protective in Persons With HIV

WEDNESDAY, Oct. 26, 2022 -- For persons living with HIV (PLWH), a three-dose hepatitis B virus (HBV) vaccine adjuvanted to a TLR-9 agonist (HepB-CpG) yields 100 percent seroprotection, according to a study presented at the annual meeting of the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news